期刊名称：CURRENT MOLECULAR MEDICINE
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Current Molecular Medicine is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews on fundamental molecular mechanisms of disease pathogenesis, the development of molecular-diagnosis and/or novel approaches to rational treatment. The reviews should be of significant interest to basic researchers and clinical investigators in molecular medicine. Periodically the journal will invite guest editors to devote an issue on a basic research area that shows promise to advance our understanding of the molecular mechanism(s) of a disease or has potential for clinical applications.
Instructions to Authors
Review articls should be submitted to the Editor-in-Chief without prior invitation at the following address:
Dr. Anil B. Mukherjee
Editor-in-Chief
Current Molecular Medicine
Head, Section on Developmental Genetics
Heritable Disorders Branch
NICHD, The National Institutes of Health
Bldg. 10, Room 9S241, Bethesda
Maryland 20892-1830
USA
Tel: +1-301-496-7213
Fax: +1-301-402-6632
E-mail: mukherja@exchange.nih.gov
It is advisable that authors first submit an abstract to the Editor-in-Chief prior submitting the full manuscript. The submitted abstract should outline the intended contents and coverage of their article. For full review articles, the manuscript, written in English, should not exceed 70 pages in length (ca. 30 printed pages) and for mini-reviews a maximum of 40 pages in length (ca. 15 printed pages).
Full Length Reviews provide the reader with a comprehensive assessment of any area of experimental biology as applied to molecular medicine that is not only of unusual significance within a field of molecular medicine but also of interest to investigators beyond the boundaries of an immediate area of interest of the author(s). The authors of full length reviews are encouraged to provide their own assessment and vision for the future advances in a field of research.
Mini Reviews are welcome on late breaking discoveries on which a substantial literature have not yet been amassed. A mini-review provides a forum for sharply focused topics of recent experimental investigations in molecular medicine primarily to make these results accessible to both clinical and basic researchers. Therefore, it should be a critical but balanced assessment of the field and should not dwell the author's own published experimental results. Proposals for mini-reviews, not exceeding two type writer pages, should be submitted to the Editor-in-Chief.
The manuscript should be typed in double-spacing throughout on A-4 or US Letter (8.5x11 inches) paper. Dot matrix print or any print that is difficult to read is unacceptable. Two copies of the manuscript must accompany the original (along with a computer disk) and should be sent to the Editor-in-Chief at his address. All pages should be numbered. Abbreviations should be defined the first time that they are used in the manuscript and a list of abbreviations used should be provided.
Manuscript Organisation: The manuscript should be divided as: Title page, abstract and the main text. The text may be subdivided further according to the areas to be discussed. This should be followed by the Acknowledgement (if any) and Reference sections. The first page should contain the title, the authors names (initials and surname only), with an asterisk in front of the name of the principal author.
Conflict of Interest: Financial contributions to the work being reported should be clearly acknowledged, as should any potential conflict of interest.
Abstract: The abstract should not exceed 250 words and it should condense the essential features of the review article, with the focus on the major advances in the field.
Key Words: Authors must supply up to eight key words along with their manuscript.
Text: The main text should begin on a separate page and it may be subdivided into separate sections. The review article should mention any previous important reviews in the field and contain a comprehensive discussion starting with the general background of the field. It should then go on to discuss the salient features of recent developments. The authors should avoid presenting material which has already been published in a previous review. The reference numbers should be given in square brackets in the text. Acknowledgements should be kept to a minimum.
Tables:
- Data Tables should be submitted in Microsoft Excel or in Microsoft Word table format.
- Each table should include a title/caption explaining what the table shows. Detailed legends may then follow.
- Tables should be given on separate pages with indications on the left hand margin to the text, as to the appropriate placement of the tables.
- Tables should not contain vertical rules.
- Columns and rows of data should be made visibly distinct by ensuring the borders of each cell display as black lines.
- Tables should be numbered consecutively in order of their citation in the body of the text, with Arabic numerals.
- If a reference is cited in both the table and text, insert a lettered footnote in the table to refer to the numbered reference in the text.
- Tabular data provided as additional files can be submitted as an Excel spreadsheet.
Figures / Illustrations:
All authors must strictly follow the guidelines below for preparing illustrations for publication in Current Molecular Medicine.
Editorial Requirements:
The quality of the illustrations printed in the journal largely depends on the quality of the figures/illustration provided by the author. In preparing artwork or graphics for publication, keep in mind the following points.
- Submit the original artwork or a photographic print of the original for publication.
- Do not submit photocopies. (Hardcopy submission requirement).
- Illustrations should be provided as separate files, not embedded in the text. (Hardcopy submission requirement).
- Remove all color from graphics except for those illustrations (Greyscale), which are intended to be printed in color.
- Good quality of hardcopy originals are a requirement.
- Figures/illustrations cannot be modified or enhanced by the journal production staff.
- Figures should be referred to as “Fig. (1)? “Fig. (2)?etc. in the text with figure numbers in bold within round bracket.
- Revised manuscripts should contain a complete set of artwork and photographs.
Technical Details:
- Figures should be provided on high quality, white, smooth opaque paper. (Hardcopy requirement).
Format & Resolution:
- The following file formats can be accepted. (Preference in order of appearance): PDF, TIFF, JPEG, GIF.
- Illustrations must fit a single or double column format on the journal page, according to the following guideline below:
|
HEIGHT |
WIDTH |
|
SINGLE COLUMN |
24 cm (max) |
8.5 cm (max) |
|
DOUBLE COLUMN |
24 cm (max) |
18 cm (max) |
- Whenever possible, submit graphics that do not have to be reduced to fit the standard figure size.
- Use the best resolution available (hardcopy submission requirement). For online submission the maximum resolution is 300 dpi.
- Avoid textures and shadings giving a three-dimensional effect to the illustration.
- Symbols and lettering in the illustration should be of similar size.
- Smaller lettering is used.
- Font: Times New Roman or Helvetica is preferable. Font size: 10pt (maximum).
- Line drawings should have clear and sharp lines and should be of uniform density. Moreover, lines should be continuous without any breaks.
- Do not use lines thinner than 1 point.
Color Figures / Illustrations:
- One color plate will be published free of charge in each article. The cost for the first additional published page of color figures is US$ 635; the second additional page will be for US$ 465, and each subsequent page for US$ 315.
- Color figures should be supplied in CMYK not RGB colors.
- Required resolution for online submission is 300 dpi. In case of hardcopy submission, please use the maximum resolution available.
Photographs:
Submit high-contrast prints that are of single- or double-column width so that they will not have to be reduced when printed. Negatives are not acceptable. However, in case of hardcopy submission, color illustrations and plates can be published from 35 mm color slides.
Structures: The chemical structures must be prepared in ChemDraw (any version) and should be provided as separate file and submitted both on disk and printed formats. The structures should fit into a width of 8 cm (for structures to be inserted within single column widths) or a width of 18 cm (for structures or schemes to be inserted in double column widths).
References: All references must be numbered in the text in square brackets, e.g. [4], or [7,10-15], in order of citation in the text. Titles of journals are abbreviated according to Chemical Abstract Service Source Index.
Examples:
Journal Reference:
[1] Sambrook, J., Fritsch, T. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
[2] Schalling, M., Hudson, T.J., Beutow, K.H. and Housman, D.E. (1993) Nature Genet., 7, 135-139.
[3] Umenishi, F. and Verkman, A.S. (1998) Genomics, 47, 341-349.
Abstracts, unpublished data and personal communications (which can only be included if the permission has been obtained) should not be given in the reference section but they may be mentioned in the text with details provided as footnotes. All authors of referenced papers must be cited and there must be no use of the short hand version of et al. when citing the authors.
Manuscript Submission: Two copies of the manuscript must accompany the original along with the soft copy of the manuscript on a computer floppy disk(s) in MS Word file format (or created in any other well-known word processing software) should be submitted. To achieve rapid publication authors are encouraged to e-mail or fax their submission to the appropriate editorial office (see above) at the same time that they mail the manuscript. For even faster publication, authors are encouraged to submit their entire manuscript via Bentham’s online submission service (see below). Authors must provide their full address, telephone and fax numbers with e-Mail address with all submissions.
For expedient and speedy reviewing of author's manuscripts, authors are strongly advised to include the PDF file of their manuscript on a floppy or zip disk, into the mailing material. At the same time the package is mailed, please also send by e-mail a copy of the PDF file of the manuscript to the editorial office.
Online Manuscript Submission: (preferable)
To facilitate speedy and cost-effective submission of abstracts and manuscripts, an online submission and tracking service via Internet is being offered. Once the Editor-in-Chief of the journal has accepted your abstract, we would prefer that you submit your full manuscript online via our online submission service available at www.bentham-mps.org
For online submission, please provide your complete manuscript in the form of a single zipped folder containing all the material (main text, figures/ illustrations, scanned photographs, tables, chemical structures drawn in ChemDraw) as separate files and a PDF version of the entire manuscript with all the figures/ illustrations / tables / chemical structures etc., embedded in the text exactly in the manner as they should appear in printing. Authors are required to proofread the PDF version of their manuscript before submission. The article will be published exactly as received and the Publishers will not be responsible for any error occurring in the manuscript in this regard.
For online submission of manuscripts, these should be submitted via our online manuscript submission service available at www.bentham-mps.org or by FTP submission at www.bentham-ftp.org
You may, however, still submit your abstracts and manuscripts through conventional surface mail.
Page Charges: No page charges will be levied to authors.
Proofs: Authors are sent page proofs. To avoid delays in publication, proofs should be checked immediately for typographical errors and returned within 48 hours. Major changes are not acceptable at the proof stage.
Copyright: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.
Bentham Open Access: Accepted articles can be published online for an immediate free open access for all to view. Authors must pay for this service.
Reprints: Each first named author will receive a free copy of the journal issue in which their article is published. Reprints may be ordered from the Publisher. First named authors may also order a personal print and online subscription of the journal at 50% off the normal subscription rate by contacting the subscription department at e-mail: subscriptions@bentham.org
Reviewing and Promptness of Publication: All papers submitted for publication will be immediately subjected to editorial scrutiny, usually in consultation with members of the Editorial Advisory Board. Every effort will be made to assess the papers quickly. The papers will be typeset and the proofs despatched to the authors normally within 4 weeks of their acceptance.
Please provide your telephone and fax numbers with your e-Mail address with all submissions
Editorial Board
Editor-in-Chief:
Anil B. Mukherjee
Head, Section on Developmental Genetics
Heritable Disorders Branch, NICHD
and Medical Director, Commissioned Corps
US Public Health Service
The National Institutes of Health
Bldg. 10, Room 9S241
Bethesda, Maryland 20892-1830
USA
Tel: +1-(301) 496-7213; FAX: (301) 402-6632,
E-mail: mukherja@exchange.nih.gov
Associate Editors:
Mark A. Atkinson
Department of Pathology
University of Florida
Gainesville, FL
USA
Michael C. Carroll
Harvard Medical School
Boston, MA
USA
Dale A. Cooper
The Procter & Gamble Co.
Cincinnati, Ohio
USA
Bryan R. Cullen
Departments of Genetics and Microbiology
Duke University Medical Center
Durham, NC
USA
Ronald C. Desrosiers
Harvard Medical School
Southborough, Massachusetts 01772-9102
USA
Ulf Dittmer
Institut für Virologie
der Universitaet Wuerzburg
Wuerzburg
Germany
Michael Emerman
Fred Hutchinson Cancer Research Center
Seattle, WA
USA
David A. Frank
Dana-Farber Cancer Institute
Harvard Medical School
Boston, MA
USA
Philippe Froguel
Department of Human Genetics
Institut Pasteur de Lille, Lille
France
Alfred L. George, Jr.
Division of Genetic Medicine
Vanderbilt University
Nashville, TN
USA
Michel Goedert
MRC Laboratory of Molecular Biology
Cambridge
UK
Tomas Hanke
Institute of Molecular Medicine
University of Oxford
Oxford
UK
Andrew T. Hattersley
Department of Diabetes and
Vascular Medicine
University of Exeter
Exeter
UK
Syed R. Husain
Laboratory of Molecular Tumor Biology
Center for Biologics and Research Evaluation
FDA, NIH, Bethesda, MD
USA
David H. Kirn
Vice President, Clinical Research
Onyx Pharmaceuticals
Richmond, CA
USA
Theodore G. Krontiris
Division of Molecular Medicine
Beckman Research Institute of the
City of Hope National Medical Center
Duarte, CA
USA
Kazuyoshi Kuwano
Research Institute for Diseases of the Chest
Kyushu University
Fukuoka
Japan
Stuart A. Lipton
Center for Neuroscience and Aging
The Burnham Institute
La Jolla, CA
USA
Anirban Maitra
Dept of Pathology
UTSW Med Ctr
Dallas TX
USA
Peter R. Martin
Director, Division of Addiction Medicine
and Vanderbilt Addiction Center
Vanderbilt University Medical Center
Nashville TN
USA
Kouji Matsushima
Department of Molecular Preventative Medicine
University of Tokyo
Tokyo
Japan
Hugo W. Moser
Director, Neurogenetics Research Center
Johns Hopkins University
Baltimore, MD
USA
Barid B. Mukherjee
Department of Human Genetics
McGill University
Montreal, Quebec
Canada
Peary L. Ogra
Department of Pediatrics
State University of New York at Buffalo
The Childerns Hospital at Buffalo
Buffalo, NY
USA
Fabrizio Poccia
International Center for AIDS & Emerging Infections (ICAERI)
Institute for Infectious Diseases "Lazzaro Spallanzani"
Rome,
Italy
Owen M. Rennert
The National Institute of Child Health and
Human Development
The National Institutes of Health
Bethesda, MD
USA
Griffin P. Rodgers
Chief, Molecular and Clinical Hematology Branch
National Institutes of Health
Bethesda, MD
USA
Gunther Schutz
Molecular Biology of the Cell I
German Cancer Research Center
Heidelberg
Germany
Michael W. Schwartz
Head, Section of Clinical Nutrition
University of Washington and
Harborview Medical Center
Seattle, WA
USA
Mario Stevenson
University of Massachusetts Medical Center
Program in Molecular Medicine
Worcester, Massachusetts
USA
Jeffrey A. Towbin
Department of Pediatrics (Cardiology)
Baylor College of Medicine,
Houston, Texas
USA
Mats Wahlgren
Karolinska Instiutet
Microbiology Tumor Biology Center (MTC)
Stockholm
Sweden
William V. Williams
Department of Clinical Pharmacology
Smithkline Beecham,
Philadelphia, PA
USA
F. Susan Wong
Department of Pathology and Microbiology
University of Bristol
Bristol
UK
Editorial Advisory Board:
Domenico Accili (Columbia University School of Medicine, NY, USA)
Lydia Aguilar-Bryan (Baylor College of Medicine, Houston, TX, USA)
Shakeel Ahmad (Georgetown University Medical Center, Washington DC, USA)
Anna Aldovini (University of Massachusetts Medical Center, Worcester, MA, USA)
Peter J. Barnes (Imperial College School of Medicine, London, UK)
Greg Barsh (Stanford University School of Medicine, Stanford, CA, USA)
Luca Battistini (I.R.C.C.S Santa Lucia, Via Ardeatina, Rome, Italy)
Azad Bonni (Harvard Medical School, Boston, MA, USA)
William T. Butler (University of Texas Houston, Dental Branch, TX, USA)
Ann F. Chambers (London Regional Cancer center, London, ON, Canada)
Wai Yee Chan (Georgetown University Medical Center, Washington DC, USA)
Peter K. Chiang (Tropical Disease Unit, San Francisco, CA, USA)
Hubert Shih-Han Chou (SmithKline Beecham, Philadelphia, PA, USA)
Janice Y. Chou (Heritable Disorders Branch, NICHD, Bethesda, MD, USA)
Vittorio Collizzi (University of Rome, Rome, Italy)
Pierre Corvol (College de France, Paris, France)
Garry R. Cutting (Institute of Genetic Medicine, Baltimore, MD, USA)
Theodore Marc Danoff (SmithKline Beecham, Philadelphia, PA, USA)
Sridevi Devaraj (University of Texas, TX, USA)
Bonnie Dittel (The Blood Center of Wisconsin, Milwaukee, WI, USA)
Masahito Ebina (University of Tohoku, Sendai, Japan)
Robert Eckel (University of Colorado, Denver, CO, USA)
Tim Elliott (John Radcliffe Hospital, OX, UK)
Yoshikatsu Eto (Jikei University School of Medicine, Tokyo, Japan)
Klaus Erb (Universität Würzburg, Würzburg, Germany)
James L.M. Ferrara (University of Michigan Cancer Center, Ann Arbor, MI, USA)
Jeffrey S. Flier (Beth Israel Hospital, Boston, MA, USA)
Bernard A. Fox (Oregon Health Sciences University, Portland, OR, USA)
Jonathan Charles Fox (SmithKline Beecham, Philadelphia, PA, USA)
Richard Gaynor (University of Texas Southwest Medical Center, Dallas, TX, USA)
Cecilia M. Giachelli (University of Washington, Seattle, WA, USA)
Peter Glazer (Yale University School of Medicine, New Haven, CT, USA)
Harry L. Goldsmith (The Montreal General Hospital, Montreal, QC, Canada)
Steve Goldstein (Yale University, New Haven, CT, USA)
Marie-Lise Gougeon (Institut Pasteur, Paris cedex, France)
Yoshinori Hasegawa (Nagoya University School of Medicine, Nagoya, Japan)
Kim J. Hasenkrug (National Institute of Allergy and Infectious Diseases, Hamilton, MT, USA)
Peter Herrlich (Forschungszentrum Karlsruhe, Karlsruhe, Germany)
Thomas J. Hope (The Salk Institute for Biological Studies, La Jolla, CA, USA)
R. Paul Johnson (Harvard University Medical School, Southborough, MA, USA)
Bharat Joshi (Center for Biologics Evaluation and Research FDA, Bethesda, MD, USA)
Michael Karin (University of California, La Jolla, CA, USA)
Yutaka Kawakami (Keio University, Tokyo, Japan)
Sally A. Kornbluth (Duke University Medical Center, Durham, USA)
Peter Krammer (German Cancer Research Center, Im Neuenheimer Feld, Heidelberg, Germany)
Robert J. Kreitman (National Cancer Institute NIH, Bethesda, MD, USA)
Andrew Larner (Cleveland Clinic Research Institute, Cleveland, Ohio, USA)
Rudolph L. Leibel (Columbia University, New York, NY, USA)
Miroslav Malkovsky (UW Medical School, University Avenue Madison, WI, USA)
Brian Mansfield (Beaumont Ave Catonsville, MD, USA)
Takeshi Matsuse (Yokohama City University School of Medicine, Yokohama, Japan)
Stephanie Jean Mihalik (Johns Hopkins University, Baltimore MD, USA)
William C. Mobley (Stanford University School of Medicine, Stanford, CA, USA)
Takashi Murata (Nagasaki University, Nagasaki, Japan)
Kenji Nakanishi (Hyogo College of Medicine, Hyogo, Japan)
Takashi Nishimura (Hokkaido University, Sapporo, Japan)
B. Matija Peterlin (University of California, San Francisco, CA, USA)
Melissa Pope (Center for Biomedical Research, New York, NY, USA)
Nancy J. Raab-Traub (University of North Carolina, Chapel Hill, NC, USA)
Gideon A. Rodan (Merck Research Laboratories, West Point, PA, USA)
Ulrike Sauermann (Deutsches Primatenzentrum, Goettingen, Germany)
S. Schneider-Schaulies (Universität Würzburg, Würzburg, Germany)
Gavin Screaton (Institute of Molecular Medicine, University of Oxford, Oxford, UK)
Moritaka Suga (Kumamoto University School of Medicine, Kumamoto, Japan)
Gordon F. Tomaselli (Johns Hopkins School of Medicine, Baltimore, MD, USA)
Alem Truneh (SmithKline Beecham, King of Prussia, PA, USA)
Li Wen (Yale School of Medicine, New Haven, CT, USA)
Ignacio I. Wistuba (Universidad Catolica de Chile, Santiago, Chile)
Etsuro Yamaguchi (Hokkaido University, Sapporo, Japan)
Jerome Zack (UCLA School of Medicine, Los Angeles, CA, USA)
|
